Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CAPN1 | P07384 | 5/20 | 0.46 |
| ▸ | OPRM1 | P35372 | 4/20 | 0.42 |
| ▸ | OPRD1 | P41143 | 4/20 | 0.42 |
| ▸ | CTSB | P07858 | 1/20 | 0.41 |
| ▸ | GRB2 | P62993 | 1/20 | 0.40 |
| ▸ | BDKRB2 | P30411 | 2/20 | 0.39 |
| ▸ | REN | P00797 | 1/20 | 0.38 |
| ▸ | ACE | P12821 | 1/20 | 0.38 |
| ▸ | APLNR | P35414 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31752319 | 1.00 | CAPN1 (0.46) | CAPN1OPRM1OPRD1CTSBGRB2 | |
| SCHEMBL31750671 | 0.95 | CAPN1 (0.47) | CAPN1OPRM1OPRD1CTSBGRB2 | |
| SCHEMBL30712732 | 0.95 | CAPN1 (0.47) | CAPN1OPRM1OPRD1CTSBGRB2 | |
| SCHEMBL30167004 | 0.95 | CAPN1 (0.46) | CAPN1OPRM1OPRD1CTSBGRB2 | |
| SCHEMBL29375301 | 0.95 | CAPN1 (0.46) | CAPN1OPRM1OPRD1CTSBGRB2 | |
| SCHEMBL29376366 | 0.95 | CAPN1 (0.46) | CAPN1OPRM1OPRD1CTSBGRB2 | |
| SCHEMBL29554130 | 0.94 | CAPN1 (0.47) | CAPN1OPRM1OPRD1CTSBGRB2 | |
| SCHEMBL30647293 | 0.93 | CAPN1 (0.54) | CAPN1OPRM1OPRD1CTSBGRB2 | |
| SCHEMBL29373267 | 0.92 | CAPN1 (0.44) | CAPN1OPRM1OPRD1CTSBGRB2 | |
| SCHEMBL31751216 | 0.92 | OPRM1 (0.43) | CAPN1OPRM1OPRD1CTSBREN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025264785-A1 | CHEMICALLY MODIFIED PEPTIDES AND USE THEREOF | NEUROCRINE BIOSCIENCES, INC. (US) | 2025-12-26 | — | — | WO | disclosed |
| WO-2025264809-A1 | CHEMICALLY MODIFIED PEPTIDES AND USE THEREOF | NEUROCRINE BIOSCIENCES, INC. (US) | 2025-12-26 | — | — | WO | disclosed |
| EP-4196495-A1 | EXENDIN-4 PEPTIDE ANALOGUES | TXP Pharma GmbH (CH) | 2023-06-21 | — | — | EP | disclosed |
| WO-2022034062-A1 | EXENDIN-4 PEPTIDE ANALOGUES | TXP PHARMA AG (CH) | 2022-02-17 | — | — | WO | disclosed |